title: Part 3: Understanding the manufacturing of unproven cellular therapy products.
authors.affiliation: University of North Carolina Lineberger Comprehensive Cancer Center, Advanced Cellular Therapeutics Facility, Chapel Hill, North Carolina, USA. ISCT North America, Past Regional Vice President 2012-2014. Electronic address: paul.eldridge@med.unc.edu.
authors.forename: Paul
authors.initials: P
authors.lastname: Eldridge
authors.affiliation: Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Chair, ISCT NA LRA Committee, 2014-2016 and Co-Editor of the Telegraft.
authors.forename: Deborah
authors.initials: D
authors.lastname: Griffin
authors.affiliation: St Jude Children's Research Hospital, Memphis, Tennessee, USA. ISCT Past Co-Chair, NA LRA Committee 2011-2014. ISCT North America, Regional Vice President 2014-2016.
authors.forename: William
authors.initials: W
authors.lastname: Janssen
authors.affiliation: Division of Hematology, Cell Therapy Laboratory, The Ohio State University, Columbus, Ohio, USA. ISCT Global Secretary, 2013-2016 and Editor in Chief of Telegraft.
authors.forename: Lynn
authors.initials: L
authors.lastname: O'Donnell